Search details
1.
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.
Blood
; 136(4): 387-400, 2020 07 23.
Article
in English
| MEDLINE | ID: mdl-32344427
2.
Discovery of a Non-Nucleoside SETD2 Methyltransferase Inhibitor against Acute Myeloid Leukemia.
Int J Mol Sci
; 22(18)2021 Sep 17.
Article
in English
| MEDLINE | ID: mdl-34576219
3.
Roles of SETD2 in Leukemia-Transcription, DNA-Damage, and Beyond.
Int J Mol Sci
; 20(5)2019 Feb 27.
Article
in English
| MEDLINE | ID: mdl-30818762
4.
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia.
Nat Commun
; 14(1): 5709, 2023 09 19.
Article
in English
| MEDLINE | ID: mdl-37726279
5.
Exploring protein hotspots by optimized fragment pharmacophores.
Nat Commun
; 12(1): 3201, 2021 05 27.
Article
in English
| MEDLINE | ID: mdl-34045440
6.
SETD2 in MLL-rearranged leukemia - a complex case.
Mol Cell Oncol
; 5(4): e1503492, 2018.
Article
in English
| MEDLINE | ID: mdl-30250934
7.
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity.
Nat Commun
; 9(1): 1983, 2018 05 18.
Article
in English
| MEDLINE | ID: mdl-29777171
Results
1 -
7
de 7
1
Next >
>>